8 funding opportunities found in this category. Change the order of results: Newest First Oldest First Expiring Soonest Expiring Latest Lowest Award to Highest Highest Award to Lowest
Autism Speaks Request for Applications: Treatment Research Grants: Full- and Pilot-Level 2012 Cycle
Letter of Intent due: February 23, 2012, 8:00 PM Eastern Autism Speaks invites both Full- and Pilot-Level Treatment research grant applications to conduct innovative clinical studies of novel interventions for individuals with Autism Spectrum Disorders (ASD) throughout the lifespan. These may include medical approaches including complementary and alternative forms of health care and pharmacological treatments, as well as behavioral and/or psychosocial interventions, and evaluation of the efficacy, safety or therapeutic benefits of all types of interventions. Also appropriate are animal model studies that test the effects of novel compounds for reducing autism symptoms.
For all RFAs, Autism Speaks is focusing on a set of targeted research priorities for 2012. All treatment study projects will be required to demonstrate direct relevance to at least one of these targeted research priorities:
1. Understand environmental risk factors and their interaction with genetic susceptibility to enable prevention and improve diagnosis and treatment
2. Discover biomarkers that can improve risk assessment and subtype stratification that will allow for an individualized approach to treatment
3. Improve quality of life through more effective medicines, behavioral interventions, and technologies
4. Enhance diagnosis and treatment of underserved and under-studied populations, specifically,
• Nonverbal persons with ASD • Ethnically-diverse and/or low resource communities • Adults • Those with medical co-morbidities
5. Disseminate and implement evidence-based clinical practices to the broader community worldwide IMPORTANT: The relevance of the proposed research to ASD and Autism Speaks’ research priority areas must be explicitly described in the Letter of Intent (LOI) and full application.
Awards Autism Speaks will make a limited number of treatment research grants determined by the available financial resources. Full-level research grant 1-3 years $150,000/year maximum
Pilot-level research grant 1-2 years $60,000/year maximum
Autism Speaks utilizes a web-based application system for their grant submissions. All applications must be submitted through this system. It is imperative to indicate whether the submission is for the Full- or Pilot-Level Treatment research option.
Research Inquiries research@autismspeaks.org
Epilepsy Foundation Targeted Research Initiative for Health Outcomes
Targeted Research Initiative for Health Outcomes
Application Deadline: March 21, 2012
Award Amount: up to $50,000 maximum for one year
Apply via Proposal Central website
The Targeted Research Initiative for Health Outcomes targets an important need for research to understand how different components of health care systems affect outcomes in people with epilepsy. The purpose of this initiative is to support research that generates initial data leading to more extensive projects that will generate knowledge that will ultimately improve the healthcare of persons with epilepsy. The broad focus of the proposal includes methodological aspects of health and outcome measurement, health care needs assessment, nature and determinants of disparities in healthcare, access to care, quality of life, comparative effectiveness research, insurance and healthcare system issues, and methods of health care delivery.
Applicants may request up to $50,000 maximum for one year.
Epilepsy Foundation 8301 Professional Place Landover, MD 20785-7223 Telephone: 1-800-332-1000 Fax: 1-301-577-2684 Email: ContactUs@efa.org
Epilepsy Foundation Targeted Research Initiative for Youth
The Targeted Research Initiative for Youth grant program recognizes the increasing need for epilepsy and seizure research in populations from birth through the teen years involving pathophysiology, epidemiology, diagnosis, behavioral manifestations, medication therapy, and quality-of-life issues.
The Foundation invites research grant applications from investigators interested in psychosocial problems and comorbidities of infants, children and adolescents with epilepsy including, but not limited to topics such as psychiatric comorbidity; treatment of behavioral and cognitive comorbidities, including innovative techniques such as utilization of internet or computer based technologies; studies of the impact of impaired social cognition on educational and occupational outcomes; difficulties and treatment gaps for adolescents transitioning to adulthood; social supports for adolescents with epilepsy; health access and literacy including family communication with health care professionals; the impact of other health conditions (e.g. sleep difficulties, migraines, etc.) on epilepsy treatment and outcome.
Epilepsy Foundation Targeted Research Initiative for Morbidity and Mortality
Award Amount: up to $50,000 maximum for one year Apply via Proposal Central website
The Targeted Research Initiative for Morbidity and Mortality supports research that generates initial data leading to more extensive projects that will generate knowledge that will ultimately improve the lives of persons with epilepsy. This initiative recognizes the need for research and new insights into these scientific areas.
The broad focus of the morbidity portion of this program includes: identification of somatic comorbidities in epilepsy that occur more than expected among controls, including but not limited to diabetes, gastrointestinal bleeding, chronic lung disease, congenital cardiac abnormalities, heart failure, and pneumonia; and associations between somatic comorbidities in epilepsy and epilepsy outcomes, including quality of life in epilepsy, seizure remission, stigma and other outcomes.
The mortality portion of the program is focused upon potentially preventable causes of death in epilepsy, such as accidents, suicide and SUDEP. Applicants are encouraged to examine risk factors for these causes of death in epilepsy; as well as interventions to decrease the presence of risk factors for these causes of death where risk factors have been identified.
Call for Proposals: Growing the Field of Chaplaincy Research in Palliative Care
This initiative, entitled “Growing the Field of Chaplaincy Research in Palliative Care,” aims to build capacity in the field of chaplaincy research in palliative care by creating an interdisciplinary network of experienced researchers and board-certified chaplains, promoting career development of participants, and supporting field-advancing research projects to better understand chaplaincy care in palliative care.
Funding Availability Approximately 6 to 10 grants will be made for projects that can be completed within 18 months. Please note that project extensions (also known as no-cost extensions) will not be possible. The all-inclusive award amounts will range up to a maximum of $250,000, which includes personnel, other direct costs, and indirect costs calculated at a rate not to exceed 15%.
Eligibility
HCC welcomes applications from interdisciplinary research teams comprised of health, behavioral or social scientists, health care providers, and board-certified chaplains with an interest in chaplaincy research who are affiliated with educational or health care institutions, research organizations, or other types of nonprofit organizations located in the United States or Canada. Consortia of such institutions or organizations are also welcome to apply.
Proposal Evaluation and Selection Criteria
Applications will be evaluated base on significance and innovation, investigator and research team qualifications and commitment, institutional and collateral support, approach and methods, feasibility and financial responsibility, and potential scholarly and public influence.
Key Dates and Deadlines:
March 15, 2012 (3 p.m. ET) Deadline for receipt of proposals
May 31, 2012 Applicants notified by email as to whether they have been selected to participate July 1, 2012 Project start date
How to Apply
Applications must be submitted on-line through our web site for applicants.
Award Obligations
Each team’s lead investigator(s) and board-certified chaplain (not to exceed a maximum of 3 persons per team) will be required, at HCC’s expense, to actively participate in four to five national colloquia during the grant period.
Contact for Assistance
HCC invites applicants to contact us to discuss their research teams and proposed projects. For assistance, please contact:
Robert Wolf Senior Vice President of Innovation and Development HealthCare Chaplaincy Email: jtf-applicant@healthcarechaplaincy.org Phone: 646-597-6934
Call for Applications: Scleroderma Foundation Established Investigator Grant
Grant Application Deadline: Sept. 15th annually by 5 p.m. EST
If the 15th falls on a Sat. or Sun., then the following Monday at 5 p.m. EST will be the deadline.
Purpose: The Scleroderma Foundation is seeking applications from promising established investigators both inside and outside the field of SSc research who wish to propose pilot studies to obtain preliminary data dealing with a highly innovative and/or highly relevant theme related to SSc. This grant will support pilot research that is likely to lead to more substantial unlimited research project grants from federal or non-federal sources.
Eligibility Requirements: Applications may be submitted by domestic non-profit organizations, public and private such as universities, colleges, hospitals and laboratories. Foreign organizations and institutions are eligible. Applicants must have a doctorate degree in Medicine, Osteopathy, Veterinary Medicine or one of the sciences, must have completed a postdoctoral fellowship, have been Principal Investigator on grants from the Scleroderma Foundation or other national, private or government agencies in the past.
Investigators who have questions about eligibility should contact the Scleroderma Foundation (see below).
Mechanism of Support: Applicants may request up to $75,000 (Up to 8% of the Direct Costs per year of award may be set aside as indirect costs. The indirect cost amount will be subtracted from the yearly total [up to $75,000) of the award) per year for up to two years (total for 2 years not to exceed $150,000). These awards are not renewable. Before completion of this grant, investigators are encouraged to seek more substantial continuing support for research through other grant mechanisms through private or government agencies. Replacement of the Principal Investigator on this award is not permitted. There will be no routine escalation for future years.
Awards are contingent on the availability of funds and the receipt of sufficiently meritorious applications meeting the stated eligibility requirements.
Research Objectives: The Scleroderma Foundation Innovative Grant is designed to facilitate highly innovative or highly relevant and meritorious pilot projects by established investigators in areas of research related to SSc that will culminate in more substantial funding from Federal or non-federal granting agencies such as the National Institutes of Health, National Science Foundation and the Department of Defense or Veterans Affairs.
Appropriate research areas may include but are not limited to the following as they relate to scleroderma:
Vascular manifestations. Studies of animal models. Therapeutic modalities. Mechanisms of end organ damage. Immunologic studies. Endothelial cell biology. Fibroblast biology. Models and markers of gender and genetic factors. Cell signaling. Epidemiology studies. Matrix biology. Stem cell biology. Health services research (e.g. quality of life, health care delivery.) Study of clinical manifestation.
Scleroderma Foundation 300 Rosewood Drive, Suite 105 Danvers, MA 01923
Phone: (978) 463-5843 (8:30 a.m. to 5 p.m. ET, Monday through Friday) Fax: (978) 463-5809 Toll-free: (800) 722-HOPE (4673)
Call for Applications: Scleroderma Foundation New Investigator Grant
Purpose: The Scleroderma Foundation is seeking applications from promising new investigators who hold faculty or equivalent positions and who wish to pursue a career in research related to systemic sclerosis (SSc, scleroderma). This grant will support promising research that is likely to lead to individual research project grants.
Eligibility Requirements: Applications may be submitted by domestic non-profit organizations, public and private such as universities, colleges, hospitals and laboratories. Foreign organizations and institutions are not eligible. These new investigator grants may not be used to support thesis or dissertation research or fellowship training. Applicants must have a doctoral degree in Medicine, Osteopathy, Veterinary Medicine or one of the sciences and must have completed a postdoctoral fellowship by the grant award date. Applicants who have been a Principal Investigator on grants from the Scleroderma Foundation or other national, private or government agencies other than fellowship grants are not eligible for this award.
Mechanism of Support: Applicants may request up to $50,000 (Up to 8% of the Direct Costs per year of award may be set aside as indirect costs. The indirect costs will be subtracted from the yearly total (up to $50,000) of the award.) per year for up to three years (total for three years not to exceed $150,000). These awards are not renewable. Before completion of this grant, investigators are encouraged to seek continuing support for research through other grant mechanisms through private or government agencies. Replacement of the Principal Investigator on this award is not permitted. There will be no routine escalation for future years.
Research Objectives: The Scleroderma Foundation New Investigator Grant is designed to facilitate the entry of promising new investigators into areas of research related to SSc.
Trish Greene International Cancer Nursing Training Workshops
Target candidates Qualified nurses in resource-constrained countries Duration 3-5 days Available 5-15 per year
Value A maximum of US $15,000 for travel and stipend for 3 international faculty members Application closing date None. Applications are accepted at any time Notification of results Generally within 60 days of registration
Objectives
* Qualified nurses in resource-constrained countries. * Facilitate a 3 to 5 day teaching and training workshop by an international faculty of up to 3 experts for groups of qualified nurses. * Provide an opportunity for qualified nurses to augment their professional knowledge and to experience cancer nursing skills as practiced in the receiving host organisation.
Profile of host coordinator
* Appropriately qualified head of department (or similar position) of the organisation applying for and hosting the training workshop
Profile of visiting faculty
* Appropriately qualified and experienced cancer expert(s)
UICC assistance Should you be in need of advice on subject matter and running of a workshop with potentially the necessary international faculty members we may be able to provided assistance. We have expertise in the following domains but workshops do not need to be limited to these fields only:
* Biotherapy, Bone Marrow/Stem Cell Transplant, Chemotherapy, Cultural issues/Cultural diversity, Financial/Cost containment, Healthcare delivery, Oncologic Emergencies, Quality of life, Radiation Oncology, Staffing/Management, Surgical Oncology, Survivorship
Please contact fellows@uicc.org with your requests for assistance.
Note: CNTW applications are accepted in English, French, or Spanish. A special application procedure by the receiving host organization applies
Funding: Trish Greene cancer nursing training workshops are supported by an educational grant from the Oncology Nursing Society and the Oncology Nursing Foundation.
1
